Company / Operating Income
Biogen Operating Income History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$2.8B
FY2021
5-year range
$2.8B / $2.8B
FY2017-FY2021
Trend
-37.6%
vs FY2020
Sector context
#6 of 202
Health Care
What the data says
Among 202 Health Care companies, Biogen is in the top 3% for operating income. Declined from $7.0B to $2.8B over the past 2 years.
Based on SEC 10-K filings.
$2.8B in FY2021 with a 5-year CAGR of -11.2%. Top quartile in the Health Care sector.
Declined from $7.0B to $2.8B over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -21.6%
- 5-Year CAGR
- -11.2%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 202This company $2.8B Sector average $86.7M
▼
+3177.4% above sector average
Key checks
Key Insights
- 5-year CAGR of -11.2%, indicating a declining trend.
- In FY2021, operating income decreased 37.6% year-over-year.
- Ranks #6 out of 202 companies in the Health Care sector.
- Peak operating income was recorded in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $2.8B | -37.6% |
| FY2020 | $4.6B | -35.4% |
| FY2019 | $7.0B | +19.6% |
| FY2018 | $5.9B | +10.2% |
| FY2017 | $5.3B | +3.8% |
| FY2016 | $5.2B | +5.3% |
As of FY2021 · SEC 10-K · Updated Mar 3, 2026